Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function
Details for Australian Patent Application No. 2004205802 (hide)
International Classifications
Event Publications
18 August 2005 PCT application entered the National Phase
PCT publication WO2004/065540 Priority application(s): WO2004/065540
5 November 2009 Application Accepted
Published as AU-B-2004205802
4 March 2010 Standard Patent Sealed
6 September 2012 Application for Amendment
The nature of the amendment is: Amend the Patentee to read Roche GlycArt AG . Address for service in Australia - Peter Maxwell & Associates Level 6 60 Pitt Street Sydney NSW 2000
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004205811-Heat exchanger unit
2004205801-Synchronous averaging of epicyclic sun gear vibration
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser